Latest News
-

TRACK-HD reveals significant changes in pre-symptomatic HD mutation carriers and patients
⏱️ 7 min read
The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
uniQure
Expected:
May 2027
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Novartis/PTC Therapeutics
Expected:
Not disclosed
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
University of California, Irvine
Expected:
Not disclosed
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Skyhawk Therapeutics
Expected:
Not disclosed
Previously featured
-
“A Whole World of Unknown”: How Couples Live Between Today and Tomorrow with HD
-
EHDN 2026 Part 2: What’s the latest news for Huntington’s disease clinical trials?
-
EHDN 2026 Part 1: What’s next in the Huntington’s disease treatment pipeline?
-
Skyhawk’s drug trial takes flight in the US
-
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
